PMVP PMV Pharmaceuticals, Inc.
$1.40▼ -2.78%
Healthcare
Other
After hours
$1.42▲ +1.43%
Sep 11, 7:30 PM ET
Volume 538.1K
Avg Volume (10D) 1.23M
Key Metrics & Fundamentals
Market Cap
$74.84M
P/E Ratio
–
Div Yield
–%
52W Range
1.02 - 1.88
% vs 50 MA
11.23%
% vs 200 MA
10.37%
RSI-14
61.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.63
Free Cash Flow
-$14.58M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$18.86M
COGS
–
Operating Exp
$18.88M
Operating Income
-$18.88M
EBIT
-$18.88M
Pretax Income
-$18.08M
Net Income
-$18.09M
EPS (Diluted)
-0.34
Price & Volume History
Loading chart…
Recent News
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
GlobeNewswire · Sep 8, 2026 12:00 PM
PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push
Benzinga · Sep 1, 2026 1:01 PM
Top Premarket Decliners
MT Newswires · Sep 1, 2026 11:41 AM
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
GlobeNewswire · Sep 1, 2026 3:03 AM
PMV Pharmaceuticals Reports Updated Rezatapopt Ovarian Cancer Data, Commences Offering
MT Newswires · Aug 31, 2026 8:50 PM
PMV Pharma Announces Proposed Public Offering of Securities
GlobeNewswire · Aug 31, 2026 8:02 PM
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
GlobeNewswire · Aug 31, 2026 8:01 PM
PMV Pharmaceuticals (PMVP) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Aug 19, 2026 4:00 PM
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
GlobeNewswire · Aug 14, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PMVP's money flow as a full page
Social Sentiment
No Reddit posts found for PMVP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.